Stock·LSE·£
Photocure ASA operates as a specialized pharmaceutical company, managing the entire lifecycle of pharmaceutical products from initial research and development through to their manufacturing, distribution, marketing, and commercialization. Its operations span a wide geographical area, encompassing the Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European nations, and the United States. Among its primary offerings is Hexvix/Cysview, a product utilized for the detection and ongoing management of bladder cancer. Furthermore, the company is advancing Cevira, an investigational treatment aimed at addressing human papilloma virus infections and precancerous lesions found on the cervix. Photocure distributes its products to pharmaceutical wholesalers, pharmacies, and hospitals, leveraging a network of license partners. Established in 1993, the company is headquartered in Oslo, Norway.
See 0IMT.L price live on your physical desk display. Set alerts with iOS & Android apps.
